Peter Dreger, MD

CLL Program Leader
Department V of Internal Medicine, University Hospital Heidelberg
Heidelberg University Hospital
Heidelberg, Germany

N/A

Presentation(s):

• (1541946) Endpoint Surrogacy in Chronic Lymphocytic Leukemia: A Pooled Analysis of the German CLL Study Group

  Sunday, October 8, 2023
  9:15 AM – 9:25 AM EDT

• (1554032) Bendamustine, Followed by Obinutuzumab, Acalabrutinib and Venetoclax in Patients (Pts) with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL): Updated Results of the CLL2-BAAG Trial of the German CLL Study Group (GCLLSG)

  Sunday, October 8, 2023
  2:55 PM – 3:05 PM EDT